{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Antitussive",
      "Common cold",
      "Cough",
      "Respiratory tract infection",
      "Viral infection"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "26420163",
  "DateCompleted": {
    "Year": "2016",
    "Month": "12",
    "Day": "13"
  },
  "DateRevised": {
    "Year": "2018",
    "Month": "11",
    "Day": "13"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2015",
        "Month": "09",
        "Day": "29"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1007/s00408-015-9808-5"
    ],
    "Journal": {
      "ISSN": "1432-1750",
      "JournalIssue": {
        "Volume": "194",
        "Issue": "1",
        "PubDate": {
          "Year": "2016",
          "Month": "Feb"
        }
      },
      "Title": "Lung",
      "ISOAbbreviation": "Lung"
    },
    "ArticleTitle": "Treatment of Acute Cough Due to the Common Cold: Multi-component, Multi-symptom Therapy is Preferable to Single-Component, Single-Symptom Therapy--A Pro/Con Debate.",
    "Pagination": {
      "StartPage": "15",
      "EndPage": "20",
      "MedlinePgn": "15-20"
    },
    "Abstract": {
      "AbstractText": [
        "Acute viral upper respiratory tract infection, or, the common cold, affects essentially every human being, and cough is reported as its most frequent associated symptom. Billions of dollars are spent worldwide annually by individuals seeking relief from this multi-symptom syndrome. Thousands of non-prescription, over-the-counter products are available worldwide, aimed at relieving the various bothersome symptoms induced by the common cold. Differences of opinion exist as to whether optimal therapy for cough associated with the common cold consists of multi-component, multi-symptom cough/cold preparations, or, whether single-component medications, aimed at relief of specific symptoms, represent the optimal therapeutic approach. The 5th American Cough Conference, held in Washington, D.C. in June, 2015, provided an ideal forum for discussion and debate of this issue between two internationally recognized experts in the field of the common cold and its treatment."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Common Cold Centre, Cardiff University, Cardiff, UK."
          }
        ],
        "LastName": "Eccles",
        "ForeName": "Ronald",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "University of Virginia School of Medicine, Charlottesville, VA, USA."
          }
        ],
        "LastName": "Turner",
        "ForeName": "Ronald B",
        "Initials": "RB"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Albert Einstein College of Medicine and Montefiore Medical Center, 1825 Eastchester Road, Bronx, NY, 10461, USA. pdicpin@gmail.com."
          }
        ],
        "LastName": "Dicpinigaitis",
        "ForeName": "Peter V",
        "Initials": "PV"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Lung",
    "NlmUniqueID": "7701875",
    "ISSNLinking": "0341-2040"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Analgesics"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antitussive Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Cholinergic Antagonists"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Drug Combinations"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Expectorants"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Histamine Antagonists"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Nasal Decongestants"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Acute Disease"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Analgesics"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antitussive Agents"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Cholinergic Antagonists"
    },
    {
      "QualifierName": [
        "complications",
        "drug therapy"
      ],
      "DescriptorName": "Common Cold"
    },
    {
      "QualifierName": [
        "drug therapy",
        "virology"
      ],
      "DescriptorName": "Cough"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Combinations"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug-Related Side Effects and Adverse Reactions"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Expectorants"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Histamine Antagonists"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Medication Adherence"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Nasal Decongestants"
    }
  ]
}